280 related articles for article (PubMed ID: 16888152)
1. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
Perrin MH; Grace CR; Riek R; Vale WW
Ann N Y Acad Sci; 2006 Jul; 1070():105-19. PubMed ID: 16888152
[TBL] [Abstract][Full Text] [Related]
2. Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand.
Grace CR; Perrin MH; Gulyas J; Digruccio MR; Cantle JP; Rivier JE; Vale WW; Riek R
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4858-63. PubMed ID: 17360332
[TBL] [Abstract][Full Text] [Related]
3. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
4. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.
Hauger RL; Grigoriadis DE; Dallman MF; Plotsky PM; Vale WW; Dautzenberg FM
Pharmacol Rev; 2003 Mar; 55(1):21-6. PubMed ID: 12615952
[TBL] [Abstract][Full Text] [Related]
5. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
6. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
[TBL] [Abstract][Full Text] [Related]
7. Distinct structural and functional roles of conserved residues in the first extracellular domain of receptors for corticotropin-releasing factor and related G-protein-coupled receptors.
Perrin MH; Grace CR; Digruccio MR; Fischer WH; Maji SK; Cantle JP; Smith S; Manning G; Vale WW; Riek R
J Biol Chem; 2007 Dec; 282(52):37529-36. PubMed ID: 17940290
[TBL] [Abstract][Full Text] [Related]
8. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
Kraetke O; Holeran B; Berger H; Escher E; Bienert M; Beyermann M
Biochemistry; 2005 Nov; 44(47):15569-77. PubMed ID: 16300406
[TBL] [Abstract][Full Text] [Related]
9. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
[TBL] [Abstract][Full Text] [Related]
10. NMR structure of the first extracellular domain of corticotropin-releasing factor receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist.
Grace CR; Perrin MH; Gulyas J; Rivier JE; Vale WW; Riek R
J Biol Chem; 2010 Dec; 285(49):38580-9. PubMed ID: 20843795
[TBL] [Abstract][Full Text] [Related]
11. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
Qi LJ; Leung AT; Xiong Y; Marx KA; Abou-Samra AB
Biochemistry; 1997 Oct; 36(41):12442-8. PubMed ID: 9376348
[TBL] [Abstract][Full Text] [Related]
12. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of a parathyroid hormone/parathyroid hormone-related peptide receptor: a member of an ancient family of G protein-coupled receptors.
Jüppner H
Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):371-8. PubMed ID: 8076140
[TBL] [Abstract][Full Text] [Related]
14. The secretin G-protein-coupled receptor family: teleost receptors.
Cardoso JC; Clark MS; Viera FA; Bridge PD; Gilles A; Power DM
J Mol Endocrinol; 2005 Jun; 34(3):753-65. PubMed ID: 15956345
[TBL] [Abstract][Full Text] [Related]
15. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
[TBL] [Abstract][Full Text] [Related]
18. Common and divergent structural features of a series of corticotropin releasing factor-related peptides.
Grace CR; Perrin MH; Cantle JP; Vale WW; Rivier JE; Riek R
J Am Chem Soc; 2007 Dec; 129(51):16102-14. PubMed ID: 18052377
[TBL] [Abstract][Full Text] [Related]
19. NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor.
Grace CR; Perrin MH; DiGruccio MR; Miller CL; Rivier JE; Vale WW; Riek R
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12836-41. PubMed ID: 15326300
[TBL] [Abstract][Full Text] [Related]
20. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
